April 4, 2023 BANGKOK — HOYA Vision Care’s MiYOSMART spectacle lenses for myopia management are taking on a new form: sun spectacle...
April 3, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Myopia can no longer be considered a benign refractive condition with...
April 3, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Eye care practitioners can prescribe several therapies for slowing progression in...
April 3, 2023 By Ornella Koumbo, PhD, Brien Holden Vision Institute Anisometropia, an inconsistency in the refractive status between the two eyes...
April 3, 2023 By Tim Fricke, BOptom, MSc, FAAO, Consultant, Brien Holden Vision Institute It is worth looking for mutual benefits —...
April 3, 2023 By David Kading, OD, FAAO, FCLSA, and Lauren Downey, OD We know that each diopter increase in myopia means...
By Erin S. Tomiyama, OD, PhD Release Date: January 15, 2023 Expiration Date: January 15, 2026 Estimated Time to Complete Activity: 2 hours Access the...
March 21, 2023 BERLIN, Germany — Professor Dr. Jens Ellrich has been named the new Chief Scientific Officer at Dopavision, a clinical-stage...
March 17, 2023 SAN RAMON, Calif. — During the first official day of Vision Expo East 2023, CooperVision introduced the myopia-focused campaign:...
March 15, 2023 NEW YORK — On Wednesday, March 15, Review of Myopia Management’s Chief Medical Editor Dwight Akerman, OD, MBA, FAAO,...
March 15, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Researchers from Taiwan analyzed the changes in visual function when progressive...
March 15, 2023 By Jeffrey Cooper, MS, OD If you are providing myopia management, it seems logical that you pay attention for...
March 15, 2023 By Brianna Rhue, OD, FAAO, FSLS We need better involvement from all health care professionals to reach as many...
March 15, 2023 By Matthew J. Martin, OD, FIAOMC Subjective A 12-year-old female Asian patient “WG” was referred to our office by...
March 13, 2023 GRAND RAPIDS, Mich. — Art Optical‘s orthokeratology lens system, MOONLENS, now has a new identification system. A unique set...
March 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Low concentration (0.01% to 0.05%) atropine effectively slows myopia progression in...
March 1, 2023 By Kate A. McClure, OD, MS, FAAO Parents who are skeptical of myopia management therapies often lack understanding and...
March 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In virtually every survey conducted in recent years, most eye care...
March 1, 2023 By Peter (Zhi) Chen, MD, PhD, Fudan University Eye and ENT Hospital, Shanghai, China Low-concentration atropine is needed only...
March 1, 2023 By Vittorio Mena OD, MS Subjective Two children, accompanied by their parents, presented at my clinic for comprehensive eye...
March 1, 2023 By Ornella Koumbo, PhD, Brien Holden Vision Institute Optical interventions that introduce myopic defocus at the peripheral retina have...
February 22, 2023 [Click here to listen to this interview.] The new chair of the 2023 board of directors of GMAC (the...
February 21, 2023 NEW YORK — Review of Myopia Management’s Chief Medical Editor Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE, and Lisa McAlister, Global...
February 15, 2023 NASHVILLE, Tenn. — U.S. pharmaceutical company Harrow has released its compounded, patent-pending formulas of low-dose atropine. Eye care professionals...
sponsored content February 15, 2023 By Zachary Holland, OD, FSLS Despite the many difficulties created during the last few years, I have...
February 15, 2023 By Jagrut Lallu, BOptom, MSc In 2009, most optometrists and ophthalmologists were not open to myopia management despite growing...
February 15, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In this editorial, Bullimore and Brennan explore a vexing research question:...